Shah VN, Peters AL, Umpierrez GE, Sherr JL, Akturk HK, Aleppo G, Bally L, Cengiz E, Cinar A, Dungan K, Fabris C, Jacobs PG, Lal RA, Mader JK, Masharani U, Prahalad P, Schmidt S, Zijlstra E, Ho CN, Ayers AT et al (2025) Consensus report on glucagon-like peptide-1 receptor agonists as adjunctive treatment for individuals with type 1 diabetes using an automated insulin delivery system
In view of patient safety and preserve the science-based drug approval pathway, the FDA has issued a significant proposal regarding popular GLP-1 medications
Understanding GLP-1 Medications: GLP-1 receptor agonists work by mimicking a naturally occurring hormone, incretin, which stimulates insulin secretion and reduces appetite
PMID: 32071395
Cotter L, Rae M, McGough M, et al
Manufacturers have launched direct-purchase programs that offer certain self-pay patients branded medication at a few hundred dollars per month, a fraction of list price, according to 2026 price reporting compiled by Forbes Health and consumer-health publishers